Social Entrepreneur’s Profile

Marc Koska

ApiJect

ApiJect’s mission is to make injectable medicine safe and available for everyone. 

The mission of the social enterprise before Corona:

Marc Koska invented and successfully mainstreamed one of the world’s first auto-disable syringe. Since beginning his work in the late 1980’s, Marc is credited with saving 10 million lives, having changed WHO policy and best practice on the ground through advocacy and campaigning. ApiJect is a rapidly growing medical technology company revolutionizing how the world gets injectable vaccine and medicines – whether it is for pandemic defense, branded and generic pharmaceuticals, or global health. In partnership with the U.S. Government, ApiJect is a founding member of The RAPID Consortium, whose purpose is to give America and its allies “surge capacity” for supplying vaccine and medicine in individual doses for injection — a capacity that strengthens population-scale defense against pandemics and other bio-emergencies.